MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,121 Cr | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr |
What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,121 Cr |
| Mar2025 | ₹2,413 Cr |
| Mar2024 | ₹2,152 Cr |
| Mar2023 | ₹1,813 Cr |
| Mar2022 | ₹920 Cr |
How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,121 Cr | 29.33 | |
| Mar2025 | ₹2,413 Cr | 12.12 | |
| Mar2024 | ₹2,152 Cr | 18.70 | |
| Mar2023 | ₹1,813 Cr | 97.15 | |
| Mar2022 | ₹920 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹103,632.0 Cr | -0.6% | 6.5% | 7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.6% |
6.5% |
7.1% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses